Saturday, October 3, 2026

Jack Ma and Elon Musk Differ on Artificial Intelligence Impact; Agree on Population Collapse

Ruchi Gupta

September 10, 2019

Elon Musk at TED 2017. Photo by: Steve Jurvetson.

The World Artificial Intelligence Conference, in Shenzhen China, was the epicenter, where two brilliant minds battle it out on what is at stake with artificial intelligence revolution. Jack Ma, the tech billionaire behind Alibaba and Tesla CEO and tech enthusiast Elon Musk, shared the stage as they echoed the potential benefits and consequences of the revolutionary technology.

Musk: AI will be smarter than Humans will

Musk might as well have rattled Ma on insisting that people are underrating the potential impact of AI. According to Musk, AI will lead to machines that are smarter than humans, something that could pose a significant danger to future generations.

Trying to understand AI according to the Tesla executive is similar to chimpanzees trying to understand humans. The Tesla CEO is also of the opinion that researchers should downplay the notion that AI will not lead to machines that are smarter than they are. Instead, they should focus on how to ensure the technology is well used not to pose a danger to the human race.

Ma, on the other hand, does not believe that AI will pose a significant danger to humans. Instead, technology should lead to potential human gains, such as making it possible for people to understand themselves better.

“I don’t think that artificial intelligence is a threat. I do not think that it is something terrible. [And] Human beings are smart enough to learn that,” said Mr. Ma before Ma interjected with famous words, “I don’t know, man”.

Reduced Working Hours

Humans, according to the tech billionaire, are smart enough to understand the technology and learn from it. For starters, the technology should transform how people work, in the future, by cutting the amount of time spent in workplaces to 12 hours a week.

The sentiments by Ma come to have a surprise in contradiction to his endorsement of a 12-hour workday culture. In April, the tech billionaire called for a change in China’s working culture, calling for people to work 9 hours a day, six days a week.

Reduced working hours, according to Ma, should allow people to live much longer given the reduced pressure from places of work. By working for fewer hours, people should be able to spend more hours in being humans rather than robots in places of work. According to MA, people should only work three days a week, four hours a day.

“In the next 20 to 30 years, human beings will live much longer. Life science technology is going to make people live probably 100 or 120 years,” he said. “That may not be a good thing because you get your grandfather’s grandfather still working hard,” added Mr. Ma.

Population Collapse Threat

Away from the disparities on AI potential impact and consequences, the two billionaires do agree on one thing: the biggest problem that the world will face in the future is the lack of enough people. According to Musk, people should dispel the notion that there are enough people in the world.

As Artificial Intelligence continues to take over all the facts of life, the biggest problem that the world will face 20 years from now is population collapse. According to the two, the world population will decrease at a much faster rate going forward contrary to popular belief that the population is rising.

Looking to the future Musk also added that people should take actions that have the potential to enhance consciousness. The fact that we are yet to encounter aliens as propagated according to the tech enthusiast makes the case as to why humans should insist on the ambitions of going to Mars.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com